We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

1 hedge funds and large institutions have $1K invested in DIPLOMAT PHARMACY, INC. in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 134 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1381 (-137)

100% less capital invested

Capital invested by funds: $227M → $1K (-$227M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 134

Holders
1
Holders Change
-137
Holders Change %
-99.28%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
134
Calls
Puts
Net Calls
Net Calls Change

DPLO Hedge Fund Activity: Q1 2020 in Review

1 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2020, worth a combined $1K — down 100% from $227M a quarter earlier.

Sellers outnumbered buyers: 134 funds closed out of DPLO and 0 opened new positions — a net loss of 134 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $37.5M sold.

  • 1 institutional investor held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2020, down from 138 in Q4 2019.
  • Funds reported $1K of DIPLOMAT PHARMACY, INC. stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2020 and 134 closed out, a net change of -134 holders.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q1 2020 was BlackRock, an estimated $37.5M sold.

Based on aggregated 13F filings for Q1 2020.